3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Head and Neck Neoplasms
2
Virus Diseases
1
Tumor Virus Infections
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
Human Papillomavirus DNA Tests
6
Colposcopy
6
Educational Status
5
Specimen Handling
4
Early Intervention, Educational
4
Vaginal Smears
3
Surveys and Questionnaires
3
Patient Navigation
3
Methods
3
epigallocatechin gallate
2
Vitamin B 12
2
Transurethral Resection of Prostate
2
Standard of Care
2
Practice Guidelines as Topic
2
Motivational Interviewing
2
Mass Screening
2
Electrocoagulation
2
Watchful Waiting
1
Triage
1
Telemedicine
1
Standing Orders
1
Referral and Consultation
1
Radiotherapy, Intensity-Modulated
1
Pregnancy Tests
1
Papanicolaou Test
1
Nimorazole
1
Mindfulness-Based Stress Reduction
1
Lacteol
1
Interviews as Topic
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Papillomavirus Infections
×
Nimorazole
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled